James M. Metz, M.D.

faculty photo
Henry K. Pancoast Professor of Radiation Oncology
Department: Radiation Oncology

Contact information
Perelman Center for Advanced Medicine
3400 Civic Center Blvd
2 West
Philadelphia, PA 19104
Office: 2156622428
Fax: 215-349-5445
Education:
BS (Biology)
Juniata College , 1989.
MS (Clinical Immunology/Microbiology)
Hahnemann University , 1991.
MD (Medicine)
UMDNJ-Robert Wood Johnson Med School, 1995.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Dr. Metz serves as Chair of Radiation Oncology at the Perelman School of Medicine and holds the Henry K. Pancoast Endowed Professorship. He is Associate Director for Clinical Services and Programs at the Abramson Comprehensive Cancer Center of the University of Pennsylvania. Dr. Metz led the development of the Roberts Proton Therapy Center, the largest proton center in the world completely integrated with conventional cancer services. Dr. Metz has become an international leader in the application of proton therapy for the treatment of a variety of malignancies. He continues to work to integrate proton therapy as a new treatment paradigm for cancer and is leading the expansion of proton therapy.

Dr. Metz specializes in the use of radiation for the treatment of gastrointestinal malignancies. His research interests include the treatment of GI malignancies in the multidisciplinary setting, as well as the utilization of complementary and alternative medications by cancer patients, and use of the Internet to provide cancer related information. A major area of interest has been the development of proton therapy at Penn and internationally.

Dr. Metz also serves as Executive Director of OncoLink (www.oncolink.upenn.edu), the award winning Internet resource from the Abramson Comprehensive Cancer Center of the University of Pennsylvania that was founded in 1994. As Executive Director, Dr. Metz leads OncoLink’s mission to help cancer patients, families, health care professionals, and the general public find accurate cancer-related information online. The website has led the way in online education for cancer patients and healthcare providers, receiving numerous awards and recognition from most major authorities as one of the best cancer information websites. Currently OncoLink is developing interactive content and personalized information for individuals while collecting important information to move the field forward, particularly in the area of cancer survivorship. Its reach is international in scope with over 285,000 unique visitors served per month.

Selected Publications

Li T, Irmen P, Liu H, Shi W, Alonso-Basanta M, Zou W, Teo BK, Metz JM, Dong L.: Dosimetric Performance and Planning/Delivery Efficiency of a Dual-Layer Stacked and Staggered MLC on Treating Multiple Small Targets: A Planning Study Based on Single-Isocenter Multi-Target Stereotactic Radiosurgery (SRS) to Brain Metastases. 2019 Jan 22;9:7. doi: 10.3389/fonc.2019.00007. eCollection 2019. Front Oncol. Page: 9:7, Jan 2019.

Baumann BC, Verginadis II, Zeng C, Bell B, Koduri S, Vachani C, MacArthur KM, Solberg TD, Koumenis C, Metz JM.: Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments. JAMA Oncol. 1(4): 1742-1748, Dec 2018

Baumann BC, Verginadis II, Zeng C, Bell B, Koduri S, Vachani C, MacArthur KM, Solberg TD, Koumenis C, Metz JM. : Assessing the Validity of Clinician Advice That Patients Avoid Use of Topical Agents Before Daily Radiotherapy Treatments. JAMA Oncol. 4(12): 1742-1748, Dec 2018.

Frick MA, Vachani CC, Hampshire MK, Bach C, Arnold-Korzeniowski K, Metz JM, Hill-Kayser CE: Patient-Reported Survivorship Care Practices and Late Effects After Treatment of Hodgkin and Non-Hodgkin Lymphoma. JCO Clin Cancer Inform. (2), 1-10, Dec 2018.

Li T, Scheuermann R, Lin A, Teo BK, Zou W, Swisher-McClure S, Alonso-Basanta M, Lukens JN, Fotouhi Ghiam A, Kennedy C, Kim MM, Mihailidis D, Metz JM, Dong L: Impact of Multi-leaf Collimator Parameters on Head and Neck Plan Quality and Delivery: A Comparison between Halcyon™ and Truebeam® Treatment Delivery Systems. Cureus. 2018 Nov 28;10(11):e3648. doi: 10.7759/cureus.3648. Nov 2018.

Benci JL, Vachani CC, Bach C, Arnold-Korzeniowski K, Hampshire MK, Metz JM, Hill-Kayser CE. : Identifying barriers to cancer survivors sharing their survivorship care plans with their healthcare provider. J Cancer Surviv. 12(5): 632-638, October 2018.

Kennedy C, Freedman G, Taunk N, Scheuermann R, Dong L, Metz JM, Li T.: Whole Breast Irradiation with Halcyon™ 2.0: Workflow and Efficiency of Field-in-Field Treatment with Dynamic Beam Flattening Technique and kV Cone Beam Computed Tomography. Cureus 29(10): 10, October 2018.

Venigalla S, Chowdhry AK, Wojcieszynski AP, Lukens JN, Plastaras JP, Metz JM, Ben-Josef E, Mahmoud NN, Reiss KA, Shabason JE. : Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer. Clin Colorectal Cancer. 17(3): e557-e568, September 2018.

Szalda D1,2, Schapira MM3, Jacobs LA1, Palmer SC1, Vachani C4, Metz J4, Hill-Kayser C2,4. : Survivorship Care Planning for Young Adults After Cancer Treatment:Preliminary Understanding Care Patterns and Patient-Reported Outcomes. J Adolesc Young Adult Oncol. 7(4): 430-437, Aug 2018.

Peach MS, Trifiletti DM, Vachani C, Arnold-Korzeniowski K, Bach C, Hampshire M, Metz JM, Hill-Kayser CE : Patient-reported outcomes in head and neck cancer: prospective multi-institutional patient-reported toxicity. Patient Relat Outcome Meas. 9: 245-252, Jul 27 2018.

back to top
Last updated: 05/27/2019
The Trustees of the University of Pennsylvania